Literature DB >> 26697910

Sustainability in Biobanking: Model of Biobank Graz.

Karine Sargsyan1, Tanja Macheiner1, Petra Story1, Manuela Strahlhofer-Augsten1, Katharina Plattner1, Skaiste Riegler1, Gabriele Granitz1, Michaela Bayer1, Berthold Huppertz1.   

Abstract

Research infrastructures remain the key for state-of-the-art and successful research. In the last few decades, biobanks have become increasingly important in this field through standardization of biospecimen processing, sample storage, and standardized data management. Research infrastructure in cohort studies and other sample collection activities are currently experiencing a lack of long-term funding. In this article, the Biobank Graz discusses these aspects of sustainability including the definition of sustainability and necessity of a business plan, as well as cost calculation model in the field of biobanking. The economic state, critical success factors, and important operational issues are reviewed and described by the authors, using the example of the Biobank Graz. Sustainability in the field of biobanking is a globally important matter of necessity, starting from policy making and ending with security and documentation on each operational level.

Mesh:

Year:  2015        PMID: 26697910     DOI: 10.1089/bio.2015.0087

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  9 in total

1.  Achieving and Maintaining Sustainability in Biobanking Through Business Planning, Marketing, and Access.

Authors:  Marianne K Henderson; Kirstin Goldring; Daniel Simeon-Dubach
Journal:  Biopreserv Biobank       Date:  2016-11-18       Impact factor: 2.300

2.  Trends in Biobanking Business Planning: Initial Results of a Survey of Biobankers.

Authors:  Daniel Simeon-Dubach; Kirstin Goldring; Marianne K Henderson
Journal:  Biopreserv Biobank       Date:  2016-12-12       Impact factor: 2.300

3.  Biospecimen User Fees: Global Feedback on a Calculator Tool.

Authors:  Lise A M Matzke; Sindy Babinszky; Alex Slotty; Anna Meredith; Tania Castillo-Pelayo; Marianne K Henderson; Daniel Simeon-Dubach; Brent Schacter; Peter H Watson
Journal:  Biopreserv Biobank       Date:  2016-08-30       Impact factor: 2.300

4.  Biobanking of different body fluids within the frame of IVF-a standard operating procedure to improve reproductive biology research.

Authors:  Michael Schenk; Berthold Huppertz; Barbara Obermayer-Pietsch; Darja Kastelic; Martina Hörmann-Kröpfl; Gregor Weiss
Journal:  J Assist Reprod Genet       Date:  2016-11-26       Impact factor: 3.412

5.  Genome Database of the Latvian Population (LGDB): Design, Goals, and Primary Results.

Authors:  Vita Rovite; Yael Wolff-Sagi; Linda Zaharenko; Liene Nikitina-Zake; Elmars Grens; Janis Klovins
Journal:  J Epidemiol       Date:  2018-03-24       Impact factor: 3.211

6.  Pediatric biobanks and parents of disabled children associations opinions on establishing children repositories in developing countries.

Authors:  Svetlana Mykolaivna Gramatiuk; Irina Yuriivna Bagmut; Michael Ivanivich Sheremet; Karine Sargsyan; Alla Mironovna Yushko; Serhii Mykolaevich Filipchenko; Vitaliy Vasilyevich Maksymyuk; Volodimir Volodimirovich Tarabanchuk; Petro Vasilyevich Moroz; Andriy Ivanovich Popovich
Journal:  J Med Life       Date:  2021 Jan-Mar

7.  Anticipatory Governance in Biobanking: Security and Risk Management in Digital Health.

Authors:  Dagmar Rychnovská
Journal:  Sci Eng Ethics       Date:  2021-04-21       Impact factor: 3.525

Review 8.  Biobanking and risk assessment: a comprehensive typology of risks for an adaptive risk governance.

Authors:  Kaya Akyüz; Gauthier Chassang; Melanie Goisauf; Łukasz Kozera; Signe Mezinska; Olga Tzortzatou; Michaela Th Mayrhofer
Journal:  Life Sci Soc Policy       Date:  2021-12-13

9.  Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome.

Authors:  Hanna A Schniewind; Lisa-Marie Sattler; Christoph W Haudum; Julia Münzker; Waldemar B Minich; Barbara Obermayer-Pietsch; Lutz Schomburg
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.